| |
FT |
Complications |
Urinary continence |
Erectile function |
Rectal toxicity |
Quality of life |
| Beerlage et al. [32] |
HIFU |
NR |
NR |
NR |
Rectourethral fistula 0/14 (0%)
Perineal pain 14/14 (100%) |
NR |
| Bahn et al. [33] |
Cryo |
NR |
28/28 (100%) |
24/27 (88.8%) |
NR |
NR |
| Onik et al. [34] |
Cryo |
NR |
24/25 (96%) |
44/51 (85%) |
NR |
NR |
| Ellis et al. [35] |
Cryo |
NR |
54/55 (96.4%) |
24/34 (70.6%) |
Rectourethral fistula 0/34 (0%) |
|
| Muto et al. [36] |
HIFU |
Urethral stricture 1/25 (4%) |
NR |
NR |
NR |
NR |
| Robinson et al. [37] |
Cryo |
NR |
NR |
27/122 (22%) |
NR |
Temporary deterioration of urinary function and bowel function. Permanent deterioration of sexual function. |
| Truesdale et al. [38] |
Cryo |
NR |
77/77 (100%) |
NR |
NR |
NR |
| Li et al. [39] |
HIFU and cryo |
NR |
NR |
Cryo: 22/47 (46.8%)
HIFU: 36/55 (65.5%) |
NR |
NR |
| El Fegoun et al. [40] |
HIFU |
Urinary retention 1/12 (8%)
Urinary tract infection 2/12 (16%) |
12/12 (100%) |
NR |
NR |
NR |
| Donnelly et al. [41] |
Cryo |
Genitourinary:
- Urgency/frequency 76/117 (64%)
- Retention 26/117 (22%)
- Pain 3/117 (2.6%)
Diarrhea 8/117 (6.8%)
Fecal incontinence 9/117 (7.7%)
Proctitis 2/117 (1.7%)
Gastrointestinal pain 17/117 (14.5%)
Gastrointestinal bleeding 9/117 (7.7%) |
79/117 (67.5%) |
14/48 (29.1%) |
NR |
NR |
| Ahmed et al. [42] |
HIFU |
Urinary stricture 1/20 (5%) |
18/20 (90%) |
19/20 (95%) |
- |
No. significant difference |
| Ward et al. [43] |
Cryo |
Urinary retention 6/518 (1.1%) |
499/507 (98.4%) |
169/291 (58.1%) |
Rectourethral fistula 1/507 (0.1%) |
NR |
| Bahn et al. [44] |
Cryo |
NR |
100% |
36/42 (86%) |
Rectourethral fistula 0/73 (0%) |
NR |
| Ahmed et al. [45] |
HIFU |
Urinary retention 1/41 (2.4%) |
100% |
31/35 (86%) |
Suspicion of rectourethral fistula 1/41 (2.4%) |
Significant deterioration |
| Barret et al. [46] |
HIFU and cryo |
Urinary retention 9/106 (8.5%)
Pelvic pain 1/106
Gross hematuria 1/106 (1%)
Urethral stricture 1/106 (1%) |
100% |
NR |
Rectourethral fistula with perineal abscess 1/106 (1%) |
NR |
| Napoli et al. [47] |
HIFU |
NR |
3/5 (60%) |
NR |
NR |
NR |
| Crouzet et al. [48] |
HIFU |
Urinary tract infection 39/1002 (3.9%)
Urinary retention 76/1002 (7.6%)
Bladder outlet obstruction 166/1002 (16.6%)
Hematuria 55/1002 (5.5%)
Stenosis 90/1002 (95) |
765/1002 (76%) |
79/187 (42.3%) |
Rectourethral fistula 4/1002 (0.4%) |
NR |
| Durand et al. [49] |
Cryo |
Urinary retention 7/48 (15%)
Cavernous corpus necrosis 1/48 (2%)
Urethral stenosis 1/48 (2%) |
100% |
No sign. difference of IIEF |
Perineal fistula 1/48 (2%) |
NR |
| Mendez [50] |
Cryo |
Urinary retention 7.3% |
613/620 99% |
193/332 (57.8%) |
Rectourethral fistula 2/634 (0.3%) |
|
| Barqawi et al. [51] |
Cryo |
No severe complications |
100% |
100% |
Rectourethral fistula 0/62 (0%) |
1.5 point decrease of American Urological Association Symptom score |
| Ahmed et al. [52] |
HIFU |
Dysuria 9/56 (16.1%)
Hematuria 36/56 (64.3%)
Urinary debris 2/56 (42.9%)
Urinary tract infection 10/56 (17.9%)
Urethral stricture 2/56 (3.6%) |
46/50 (92.0%) |
30/39 (76.9%) |
NR |
Very little impact of health-related quality of life |
